LIFECORE BIOMEDICAL, INC. Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions
LIFECORE BIOMEDICAL, INC. (LFCR) reported Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions of 20.10% for the 3-month period ending 2014-02-23, per its 10-Q filed 2014-03-28.
Discontinued › Notes › Equity
us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions · last filed 2014-03-28
- LIFECORE BIOMEDICAL, INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for the quarter ending 2014-02-23 was 20.10%.
- LIFECORE BIOMEDICAL, INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for the quarter ending 2013-11-24 was 20.10%.
- LIFECORE BIOMEDICAL, INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for the quarter ending 2013-08-25 was 20.10%, a 0.00% change year-over-year.
- LIFECORE BIOMEDICAL, INC. subsidiary or equity method investee, cumulative percentage ownership after all transactions for the quarter ending 2012-08-26 was 20.10%.
| Period end | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 3 month | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 6 month | Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions 9 month |
|---|---|---|---|
| 2014-02-23 | 20.10% 10-Q · filed 2014-03-28 | ||
| 2013-11-24 | 20.10% 10-Q · filed 2014-01-03 | 20.10% 10-Q · filed 2014-03-28 | |
| 2013-08-25 | 20.10% 10-Q · filed 2013-09-26 | ||
| 2013-02-24 | 20.10% 10-Q · filed 2013-04-04 | ||
| 2012-11-25 | 20.10% 10-Q · filed 2013-01-04 | ||
| 2012-08-26 | 20.10% 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |